Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Apr 2026 and Jun 2026.
- Largest single sale: $1.4M (63,656 shares) of Immunome Inc. on Apr 2, 2026. Filing
- Last sale before this period: Sep 19, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Immunome Inc. (IMNM) | Chief Financial Officer | Oct 12, 2023 | Jul 27, 2026 |
Recent filings
The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jul 23, 2026, Immunome Inc.: 47,250 shares granted. 1 filing: 1
- Jun 15, 2026, Immunome Inc.: sold 60,000 shares for $1.1M, under a disclosed plan; 60,000 shares acquired by exercising options. 1 filing: 1
- Apr 2, 2026, Immunome Inc.: sold 65,000 shares for $1.4M, under a disclosed plan; 71,561 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.